Assessment of the Long-Term Safety of Mepolizumab and Durability of Clinical Response in Patients With Severe Eosinophilic Asthma
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.09.033
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2019
Authors
Publisher
Elsevier BV